Loading clinical trials...
Loading clinical trials...
A Randomised, Double-blind, Double-dummy, Placebo Controlled (With Rescue Medication), Multicenter Study to Evaluate the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Persistent Asthma in Adults and Adolescents.
Conditions
Interventions
Fluticasone propionate
Fluticasone furoate
+1 more
Locations
82
United States
GSK Investigational Site
Birmingham, Alabama, United States
GSK Investigational Site
Montgomery, Alabama, United States
GSK Investigational Site
Green Valley, Arizona, United States
GSK Investigational Site
Little Rock, Arkansas, United States
GSK Investigational Site
Bakersfield, California, United States
GSK Investigational Site
Encinitas, California, United States
Start Date
June 30, 2010
Primary Completion Date
January 1, 2012
Completion Date
January 16, 2012
Last Updated
November 9, 2017
NCT07431021
NCT06003569
NCT07282886
NCT05562466
NCT07219173
NCT02327897
Lead Sponsor
GlaxoSmithKline
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions